AI in medical device manufacturing, Medtech, Agentic AI

An RFP can take a medical device components procurement planner an hour or more to complete. Not necessarily because the work is complicated — because it takes some thought about the various suppliers, and the effort can involve manual, repetitive tasks, and those stand between them and the decisions that actually matter. Multiply that by every item, every order, every day, for a facility running on tight margins to be competitive, and tight regulatory scrutiny, and hours become the quiet tax medtech manufacturers pay just to keep the lights on.

Then one QAD customer cut that same task to under 30 seconds.

That’s not a rounding error, it’s a different job. When AI absorbs the administrative grind, buyers and planners don’t just work faster; they recover 50 to 80% of time previously lost to manual tasks, time that shifts toward supplier risk management, cost containment, and the strategic calls only humans should make.

Here’s the distinction worth sitting with: a traditional ERP is a System of Record — it tells you what already happened. QAD’s ChampionAI, built on more than 40 years of medical device manufacturing data, makes it a System of Action — one that predicts, flags, and acts, with humans still holding the wheel.

For an industry where every minute is regulated, every dataset is scrutinized, and every margin must drive profitability, that’s not a productivity story. It’s a survival one. The manufacturers making strides aren’t the ones running the most AI pilots or agents, they’re the ones turning seconds saved into decisions made.

Need help deciding where ChampionAI agents could make the biggest difference to your material costs? Get Medical Product Outsourcing (MPO)’s latest eBook, “Manufacturing Intelligently,” which dives into the growing use of AI within medtech manufacturing and the benefits it provides.

Robyn Coward is the Life Sciences Director at QAD. With 21 years of experience in product commercialization, Robyn has spent the last 11 years focused on the global life sciences markets, particularly in the imaging, laboratory diagnostics, and healthcare IT segments. In her role, Robyn monitors and reports on the trends impacting QAD's life sciences customers. She is a member of several industry organizations including the Medical Device Contract Manufacturing Trends Group, Life Sciences Technology and Compliance Group, and the Healthcare Businesswomen's Association. Robyn also participates in various Biocom Institute activities, and enjoys residing in the San Francisco Bay area, one of the world's top hubs for biotechnology, pharmaceutical and medical device development and manufacturing, where she can see exciting and emerging healthcare innovations before they hit the market.

LEAVE A REPLY